Winston Kung
2023
In 2023, Winston Kung earned a total compensation of $1.3M as Former Chief Operating Officer and Chief Financial Officer at PMV Pharmaceuticals, a 29% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $181,000 |
|---|---|
| Option Awards | $603,960 |
| Salary | $475,299 |
| Total | $1,260,259 |
Kung received $604K in option awards, accounting for 48% of the total pay in 2023.
Kung also received $181K in non-equity incentive plan and $475.3K in salary.
Rankings
In 2023, Winston Kung's compensation ranked 961st out of 2,978 executives tracked by ExecPay. In other words, Kung earned more than 67.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 961 out of 2,978 | 68th |
Division Manufacturing | 569 out of 1,637 | 65th |
Major group Chemicals And Allied Products | 388 out of 906 | 57th |
Industry group Drugs | 377 out of 869 | 57th |
Industry Pharmaceutical Preparations | 255 out of 627 | 59th |
Source: SEC filing on April 24, 2024.
Kung's colleagues
We found two more compensation records of executives who worked with Winston Kung at PMV Pharmaceuticals in 2023.